Ownership history in WOLVERINE TRADING, LLC · 58 quarters on record
This page tracks every 13F SEC filing in which WOLVERINE TRADING, LLC reported a position in SAGE THERAPEUTICS INC (SAGE). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q2 | REDUCED | 18,390 | -110 | -0.6% | 0.00% | $168K | — |
| 2025 Q2 | ADDED | 18,500 | +6,865 | +59.0% | 0.00% | $169K | — |
| 2025 Q1 | REDUCED | 11,635 | -765 | -6.2% | 0.00% | $96K | — |
| 2024 Q4 | REDUCED | 12,400 | -6,700 | -35.1% | 0.00% | $67K | — |